Calyx Chemicals & Pharmaceuticals Ltd.

Divi’s Laboratories Limited (Divi’s), is a pharmaceutical company headquartered in Hyderabad, India.
Divi’s is engaged in manufacturing leading generic compounds, nutraceutical ingredients and custom synthesis of APIs and intermediates for global innovator companies primarily for export to regulated markets such as US and Europe. With two manufacturing facilities, market presence across several countries and a team of 10,000 employees, Divi’s continues to innovate to bring robust techniques to facilitating sustainable manufacturing processes.

The company was founded in 1990 by Dr. Murali K Divi with research and development as its core area. Started initially as a Research and Development Center, it expanded and focused on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates, providing complete turnkey solutions and consulting to the domestic pharmaceutical industry.

Established in 1951, Fermenta Biotech Limited (FBL) is one of the largest manufacturers of Vitamin D3 and a key global player. Headquartered in Thane, India, FBL caters to clientele across the globe, with a worldwide distribution network. Its state-of-the-art R&D centre is based at Thane, and world class manufacturing facilities are located in Kullu, Himachal Pradesh and Dahej, Gujarat. Apart from Vitamin D3, FBL also offers niche APIs, integrated biotechnology platforms such as enzymes for antibiotic synthesis as well as environmental solutions for waste water management and treatment.

Pharmaffiliates Analytics & Synthetics (P) Ltd, is an integrated Contract Research Organisation (CRO) services provider offering its expertise in Custom synthesis (Reference standards, Impurities, Metabolites, Deuterated compounds and Phyto standards), Analytical research (PH Buffer Solutions, Method development, Validation), Stability studies, Formulation & Development (New Drug Delivery System), Quality assurance and Regulatory services with a right blend of competent people, state of the art infrastructure facilities, cutting-edge technology and certified processes to pump your development pipeline with time and cost advantages.

Our expertise will also enable you to combat in the highly competitive markets and also in acquiring the niche segments. We desire to be your strategic partner for outsourcing and help you right from strategic planning of CMC blue-print to accelerating the filing and representation for NDAs and ANDAs submitted in any regulated and semi-regulated markets which can reduce your time and efforts for focusing them in your core areas of operations.

Since its inception in 2001, Pharmaffiliates has been serving customers across the globe comprising major Pharmaceutical companies, API manufacturers, Bulk drug suppliers, clinical CROs and other allied industries. Pharmaffiliates comes up with ISO certified ISO 9001:2008. Our effectiveness in successful service delivery has had its origin in our endeavor to carry out projects efficiently, on time and at a reasonable cost.

Welcome to Angene
Angene is pledged to providing quality chemicals for use in research and development and commercial manufacturing. Angenes offers over 100,000 products including lab reagents, intermediates, bulk commodities, agro-chemicals, natural ingredients and active pharmaceutical ingredients (APIs). In addition to the 100,000+ products, Angene offers custom synthesis of chemicals that are not commercially available.

Please contact us for quotation at sales@angenechemical.com.

Founded in 2004, Sundia MediTech Company, Ltd. is a leading pre-clinical contract research organization (CRO) providing a comprehensive and integrated portfolio of high-quality drug discovery and development services. Sundia's experienced R&D and international management team possess extensive experience across the fields of chemistry (custom synthesis, library design and synthesis), medicinal chemistry, biology (in vitro and in vivo), DMPK, pre-clinical studies, as well as pharmaceutical development (process research and development, API manufacturing, pre-formulation and formulation, analytical as well as QA/QC, CMC and IND filing) services.

Sundia's primary research facilities, which include standard and kilo-labs, an animal facility, a pilot plant and other supporting facilities, are located in Shanghai (Zhangjiang Hi-Tech Park), Shijiazhuang and Taicang. For more information, please visit us at www.sundia.com or email us at info@sundia.com.